Summary

Global Poultry Diagnostics Market was valued at USD 487.68 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.31% through 2029. The Global Poultry Diagnostics Market is driven by several factors contributing to its growth. Key drivers include increasing incidences of poultry diseases worldwide, such as avian influenza and Newcastle disease, which necessitate rapid and accurate diagnostic solutions. The rise in poultry consumption globally, driven by growing populations and dietary preferences, also fuels the demand for effective disease management and surveillance tools. Stringent regulations governing food safety and animal health encourage poultry producers to adopt advanced diagnostic technologies to ensure product quality and compliance. Technological advancements in diagnostic techniques, such as PCR, ELISA, and next-generation sequencing, enhance diagnostic accuracy and efficiency, further propelling market growth. The focus on preventive healthcare in poultry farming to mitigate economic losses from disease outbreaks continues to stimulate investments in innovative diagnostic solutions.
Key Market Drivers
Increasing Incidences of Poultry Diseases
The increase in poultry diseases worldwide, including notable pathogens such as avian influenza, Newcastle disease, and infectious bronchitis, has profoundly impacted the poultry industry. These diseases not only jeopardize poultry health but also pose substantial economic risks to producers globally. Avian influenza, for instance, can lead to severe outbreaks with high mortality rates among poultry flocks, resulting in significant financial losses due to reduced productivity and trade restrictions. Similarly, Newcastle disease and infectious bronchitis also cause respiratory distress and decreased egg production, further impacting profitability. According to a recent study aimed to investigate the prevalence of poultry diseases in the Barishal district of Bangladesh was conducted from October 2018 to September 2019. A total of 863 poultry birds, either dead or sick, were examined. The diagnosis was based on history, owner’s complaints, clinical signs, and post-mortem findings. The prevalence of diseases was highest among layers (48.20%), followed by broilers (35.34%) and Sonali chickens (16.45%). The most prevalent diseases overall were infectious bursal disease (IBD) (18.08%), salmonellosis (15.41%), Newcastle disease (ND) (13.33%), mycoplasmosis/chronic respiratory disease (CRD) (12.28%), colibacillosis (10.31%), coccidiosis (7.53%), infectious bronchitis (7.18%), aspergillosis (5.68%), omphalitis (2.55%), fowl cholera (2.43%), infectious coryza (2.09%), fowl pox (1.51%), necrotic enteritis (1.16%), and Marek's disease (0.46%). Salmonellosis (27.87%), IBD (17.79%), and ND (22.54%) were most prevalent in layers, broilers, and Sonali chickens, respectively. Diseases were most prevalent in the summer (39.75%), followed by winter (32.33%) and the rainy season (27.93%). The study underscores the importance of vaccination, strict biosecurity, hygienic management, and other preventive measures to effectively control poultry diseases and ensure sustainable development in poultry farming in the region.
In response to these challenges, there is a heightened demand for advanced diagnostic solutions within the poultry sector. Accurate and rapid diagnostic tools are essential for early detection and effective management of these diseases. Timely diagnosis enables poultry producers to implement necessary control measures swiftly, such as quarantine protocols, vaccination campaigns, and targeted treatment strategies. This proactive approach not only helps mitigate the spread of diseases within poultry populations but also ensures compliance with stringent biosecurity measures and regulatory requirements. The adoption of advanced diagnostic technologies like polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and next-generation sequencing (NGS) plays a crucial role in enhancing the sensitivity, specificity, and speed of disease detection. These technologies enable veterinarians and poultry health professionals to identify pathogens accurately and differentiate between strains, facilitating informed decision-making and precise disease management strategies.
Rising Demand for Poultry Products
The global population is steadily rising, accompanied by a notable shift in dietary preferences towards higher protein consumption, particularly in developing regions. This trend is significantly boosting the demand for poultry products, which are valued for their affordability, nutritional value, and versatility in culinary applications. As more people worldwide integrate poultry into their diets, the poultry industry faces heightened pressure to meet escalating demand while maintaining stringent standards for food safety and animal health.
In response to this growing demand, effective disease management strategies and advanced diagnostic technologies are becoming increasingly crucial. Poultry diseases pose substantial threats to flock health, productivity, and ultimately, the supply of poultry products to consumers. Diseases such as avian influenza, Newcastle disease, and infectious bronchitis can lead to devastating outbreaks if not promptly detected and controlled. These pathogens not only affect bird health but also jeopardize food safety and trade relations, highlighting the critical need for robust disease monitoring and management practices across poultry farms worldwide.
The implementation of reliable diagnostic technologies plays a pivotal role in ensuring the health and safety of poultry products. Modern diagnostic tools, including PCR, ELISA, and NGS, empower poultry producers and veterinarians to swiftly identify disease-causing pathogens with high accuracy and efficiency. Early detection enables proactive disease management strategies such as vaccination programs, biosecurity protocols, and targeted treatment regimens, thereby minimizing the impact of diseases on flock health and productivity.
Stringent Regulations on Food Safety
Regulatory bodies across the globe play a crucial role in safeguarding food safety and animal health within the poultry industry. These entities impose stringent guidelines and standards that poultry producers must adhere to, ensuring that the poultry products reaching consumers are safe, nutritious, and free from contaminants. Key regulations focus on disease prevention, control measures, and the use of diagnostic tools to monitor and manage poultry health effectively. Compliance with regulatory requirements necessitates the adoption of reliable and accredited diagnostic tests within poultry farming operations. These tests are essential for detecting, identifying, and monitoring pathogens that pose risks to poultry health and, by extension, to human consumers. Common regulatory concerns include diseases such as avian influenza, Salmonella, Campylobacter, and various viral and bacterial infections that can impact poultry flocks and public health.
Accurate diagnostic tools are instrumental in enabling poultry producers to demonstrate compliance with regulatory standards. Techniques such as Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), and Next-Generation Sequencing (NGS) are widely utilized for their sensitivity, specificity, and ability to detect multiple pathogens simultaneously. These technologies facilitate early disease detection, prompt intervention, and effective disease management strategies, thereby minimizing the spread of infections and mitigating economic losses.
Technological Advancements in Diagnostics
Continuous advancements in diagnostic technologies have revolutionized disease detection in the poultry industry, enhancing accuracy, speed, and sensitivity across various diagnostic processes. Key technologies such as polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and next-generation sequencing (NGS) are pivotal in driving market growth due to their ability to provide efficient and reliable diagnostic solutions. PCR, a cornerstone in molecular diagnostics, enables rapid amplification of DNA segments specific to pathogens, allowing for precise identification of viral and bacterial infections in poultry. This technology's sensitivity and specificity make it invaluable for early detection and monitoring of diseases such as avian influenza, Newcastle disease, and Salmonella. In November 2023, Ancera introduced the Salmonella System Monitoring (SSM) software, aiming to provide enhanced and timely insights into Salmonella across the poultry supply chain. Utilizing its extensive array of mobile surveillance systems, CRISPR databases, epidemiological models, and software alert systems, Ancera seeks to bolster the US poultry industry. The software is designed to mitigate risks and enhance profitability by delivering comprehensive support and real-time data analytics.
ELISA assays complement PCR by detecting specific antibodies or antigens in poultry samples, providing essential information on immune responses and pathogen presence. These assays are essential for surveillance and monitoring of disease outbreaks, contributing to effective disease management strategies and biosecurity measures on poultry farms. Next-generation sequencing (NGS) represents another leap forward in diagnostic capabilities, offering high-throughput sequencing of nucleic acids from multiple pathogens simultaneously. This technology provides comprehensive genomic information, facilitating precise characterization of pathogens and their genetic variations. NGS is particularly valuable for understanding disease epidemiology, tracing outbreaks, and monitoring genetic changes that may affect disease virulence and transmission dynamics.
The integration of these advanced diagnostic technologies into poultry disease management programs enhances overall farm productivity and profitability by reducing disease-related losses and ensuring product safety. Producers benefit from timely disease detection, enabling prompt intervention and targeted treatment strategies to minimize economic impacts.
Key Market Challenges
Diagnostic Sensitivity and Specificity
Achieving high sensitivity and specificity in diagnostic tests for poultry diseases is crucial to effectively manage outbreaks and ensure the health of poultry populations. Sensitivity refers to the ability of a test to correctly identify all positive cases of a disease, minimizing false negatives. Specificity, on the other hand, pertains to the ability of the test to correctly identify true negative cases, thereby minimizing false positives. In the context of poultry diagnostics, achieving high sensitivity is vital because it ensures that no infected birds are missed during testing. This is particularly important for diseases like avian influenza and Newcastle disease, which can spread rapidly and have significant economic consequences if not detected early. High sensitivity allows for prompt implementation of control measures such as quarantine and vaccination, helping to prevent further spread within flocks and to neighboring farms.
Conversely, high specificity ensures that healthy birds are not incorrectly identified as diseased, which is crucial for minimizing unnecessary culling or treatment costs. Variability in test performance across different poultry species and geographical regions poses a significant challenge to achieving both high sensitivity and specificity. Poultry species vary in their susceptibility to diseases and their immune responses, which can affect the reliability of diagnostic tests. Geographical factors such as climate, farming practices, and prevalent strains of pathogens can influence test accuracy.
Developing diagnostic tests that are robust across various poultry species and geographical contexts requires rigorous validation and standardization. This involves conducting studies to assess test performance under different conditions, optimizing protocols for sample collection and processing, and ensuring consistency in test results across laboratories. Collaborative efforts between researchers, diagnostic companies, veterinary authorities, and poultry producers are essential to address these challenges and improve diagnostic accuracy in poultry health management. By enhancing sensitivity and specificity, stakeholders can effectively monitor and control disease outbreaks, safeguarding poultry welfare and food security.
Cost and Accessibility
Ensuring the affordability and accessibility of diagnostic tests is crucial for effective disease management in poultry farming, especially for small-scale farmers and producers in developing regions. The cost of advanced diagnostic technologies and limited access to testing facilities pose significant barriers that can impede disease surveillance and control efforts. In many developing countries, small-scale poultry farmers often operate on tight budgets with limited financial resources allocated for healthcare and veterinary services. The high upfront costs associated with sophisticated diagnostic equipment such as PCR machines, ELISA kits, and NGS technologies can be prohibitive for these farmers. The recurring costs of consumables, maintenance, and training required to operate these technologies further contribute to their financial burden.
Accessibility to diagnostic testing facilities is another critical challenge, particularly in remote or rural areas where infrastructure and veterinary services may be inadequate or non-existent. Farmers may need to travel long distances to access testing laboratories or veterinary clinics, which increases costs and logistical challenges. Limited availability of skilled personnel trained in using and interpreting diagnostic tests can also hinder timely disease detection and intervention. The disparity in healthcare resources between urban and rural areas exacerbates the accessibility issue. Small-scale farmers in remote regions may lack the infrastructure, electricity, and internet connectivity required to utilize advanced diagnostic technologies effectively. This digital divide further limits their access to timely and accurate diagnostic services.
Key Market Trends
Growing Investments in Research and Development
Significant investments in research and development (R&D) initiatives are pivotal in driving the expansion of the global poultry diagnostics market. These investments are primarily aimed at advancing diagnostic capabilities, developing innovative testing methodologies, and addressing emerging poultry diseases. R&D efforts focus on developing novel diagnostic tests that offer improved accuracy, sensitivity, and speed in detecting pathogens and diseases affecting poultry. Manufacturers and research institutions collaborate to innovate new assays based on technologies such as polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and next-generation sequencing (NGS). These tests enable quicker identification and characterization of viral, bacterial, and parasitic infections, crucial for effective disease management on poultry farms. HatchTech Group B.V., a leading provider of advanced poultry incubation solutions from the Netherlands, completed the acquisition of NYtor B.V., a company specializing in DNA-based testing technologies. The acquisition was effective from March 31st, 2024, marks a strategic move by HatchTech to enhance its internal capabilities for innovation. In recent times, HatchTech has concentrated its efforts on developing cutting-edge technologies for microbiological analysis, particularly leveraging polymerase chain reaction (PCR) technology. This technology is pivotal in the in-ovo sexing process, which involves identifying and sorting male and female eggs during the incubation phase. This strategic focus underscores HatchTech's commitment to advancing poultry incubation methods through technological innovation.
Investments target the enhancement of existing diagnostic technologies to optimize performance and reliability. Continuous improvement efforts involve refining protocols, increasing automation, and reducing turnaround times for diagnostic results. Enhanced diagnostic platforms provide poultry producers with more efficient tools to monitor and control disease outbreaks, ultimately minimizing economic losses and maintaining flock health. R&D initiatives are focused on addressing emerging poultry diseases that pose significant threats to global poultry production. Researchers collaborate to identify new pathogens, study disease transmission dynamics, and develop targeted diagnostic solutions tailored to emerging challenges. This proactive approach ensures that poultry producers are equipped with timely and effective diagnostic tools to mitigate risks associated with evolving disease landscapes.
Expansion of Poultry Industry
The rapid expansion of the global poultry industry is catalyzing a heightened demand for reliable and advanced diagnostic solutions. This growth is primarily fueled by the intensification of poultry farming practices and the trend towards vertical integration within the industry. As poultry operations scale up to meet the escalating global demand for poultry products, there arises a critical need for effective disease management strategies that can swiftly detect and mitigate health risks among flocks.
Intensified poultry farming involves higher stocking densities and increased biosecurity challenges, which can exacerbate the spread of diseases such as avian influenza, Newcastle disease, and salmonellosis. Consequently, poultry producers are increasingly investing in robust diagnostic tools that offer accurate and rapid detection capabilities. These diagnostics play a pivotal role in monitoring flock health, preventing disease outbreaks, and ensuring food safety standards are upheld. The integration of advanced diagnostic technologies like PCR, ELISA, and next-generation sequencing is pivotal in meeting these industry demands. These technologies enhance the accuracy, sensitivity, and speed of disease detection, enabling early intervention and minimizing economic losses associated with disease outbreaks. Regulatory pressures and consumer preferences for safe and high-quality poultry products further underscore the importance of comprehensive disease monitoring and management practices supported by innovative diagnostics.
Segmental Insights
Test Type Insights
Based on the Test Type, Enzyme-Linked Immunosorbent Assay has long been a cornerstone in poultry diagnostics, renowned for its efficacy in detecting antibodies against a wide array of poultry pathogens. Its popularity stems from several key advantages, making it indispensable in veterinary laboratories worldwide. The ELISA testing process begins with coating a microplate with specific antigens or antibodies that have affinity for target molecules present in the sample. When the sample is introduced, any antibodies or antigens specific to the target pathogens bind to these coated molecules. Next, enzyme-linked antibodies are introduced, which bind specifically to the captured antigens or antibodies. These enzyme-linked antibodies are designed to react with a substrate solution that produces a detectable color change, signaling the presence and concentration of the antibodies or antigens in the sample. This color change is quantified using spectrophotometry or visual inspection, providing a straightforward and reliable method for detecting the presence of pathogens.
The simplicity and cost-effectiveness of ELISA make it highly suitable for handling large sample volumes efficiently. It is particularly effective in screening large numbers of poultry samples rapidly, making it an ideal tool for routine monitoring of flock health and screening for diseases such as avian influenza, Newcastle disease, infectious bronchitis, and others. This capability is crucial in maintaining poultry health and preventing disease outbreaks, as early detection allows for prompt implementation of control measures. ELISA's ability to detect antibodies provides valuable information about the immune status of poultry flocks. By monitoring antibody levels over time, veterinarians and poultry producers can assess the effectiveness of vaccination programs and track the prevalence of specific diseases within populations. This proactive approach aids in making informed decisions regarding disease management strategies and optimizing flock health.
Disease Type Insights
Based on the Disease Type, Avian Influenza, also known as bird flu, stands out as a dominant force in the global poultry diagnostics market due to its significant impact on poultry health, economic implications, and public health concerns. Avian Influenza is caused by influenza viruses that primarily affect birds, including domestic poultry and wild birds. It poses a dual threat: not only does it cause severe illness and death in poultry, but certain strains, such as H5N1 and H7N9, can also infect humans, leading to serious respiratory illness and even death in some cases.
The prevalence and rapid spread of Avian Influenza necessitate robust diagnostic strategies to monitor and control outbreaks effectively. Diagnostic methods for Avian Influenza include both direct virus detection and serological tests to detect antibodies produced by infected birds. Among these methods, real-time reverse transcription polymerase chain reaction (rRT-PCR) is widely used for its high sensitivity and specificity in detecting influenza virus RNA from clinical samples. This molecular technique allows for rapid and accurate identification of infected birds, enabling swift containment measures to prevent further spread within poultry populations and to humans. Serological tests, such as ELISA (Enzyme-Linked Immunosorbent Assay), are crucial for detecting antibodies against Avian Influenza viruses in poultry serum samples. These tests provide valuable information about the immune status of birds and are instrumental in monitoring the effectiveness of vaccination programs. ELISA's simplicity, cost-effectiveness, and ability to process large numbers of samples make it an essential tool in routine surveillance and epidemiological studies of Avian Influenza.
Regional Insights
North America holds a prominent position in the global poultry diagnostics market, owing to the region's well-established veterinary healthcare system and high adoption of advanced diagnostic technologies. The United States, in particular, leads the market with a strong focus on disease surveillance and biosecurity measures in poultry production. Government initiatives and regulatory support ensure stringent monitoring of poultry health, prompting the widespread use of sophisticated diagnostic tools.
The market in North America benefits from extensive research activities aimed at developing innovative diagnostic solutions for poultry diseases such as avian influenza, Newcastle disease, and salmonellosis. The presence of key market players and diagnostic laboratories specializing in poultry health further enhances the region's dominance. These factors collectively contribute to the high demand for accurate and efficient diagnostic tests that enable early disease detection and effective management strategies.
Key Market Players
• Zoetis Services LLC
• QIAGEN N.V.
• BioChek BV
• Bioneer Corporation
• Thermo Fisher Scientific Inc.
• MEGACOR Diagnostik GmbH
• IDEXX Laboratories, Inc.
• Randox Laboratories Ltd.
• INDICAL Bioscience GmbH
• Heska Corporation
Report Scope:
In this report, the Global Poultry Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Poultry Diagnostics Market, By Test Type:
o ELISA
o PCR
• Poultry Diagnostics Market, By Disease Type:
o Avian Salmonellosis
o Avian Influenza
o Newcastle Disease
o Others
• Poultry Diagnostics Market, By Region:
o North America
 United States
 Canada
 Mexico
o Europe
 France
 United Kingdom
 Italy
 Germany
 Spain
o Asia-Pacific
 China
 India
 Japan
 Australia
 South Korea
o South America
 Brazil
 Argentina
 Colombia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Poultry Diagnostics Market.
Available Customizations:
Global Poultry Diagnostics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Poultry Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Test Type (ELISA and PCR)
5.2.2. By Disease Type (Avian Salmonellosis, Avian Influenza, Newcastle Disease, and Others)
5.2.3. By Region
5.2.4. By Company (2023)
5.3. Market Map
6. North America Poultry Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test Type
6.2.2. By Disease Type
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Poultry Diagnostics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Test Type
6.3.1.2.2. By Disease Type
6.3.2. Canada Poultry Diagnostics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Test Type
6.3.2.2.2. By Disease Type
6.3.3. Mexico Poultry Diagnostics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Test Type
6.3.3.2.2. By Disease Type
7. Europe Poultry Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test Type
7.2.2. By Disease Type
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Poultry Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Test Type
7.3.1.2.2. By Disease Type
7.3.2. United Kingdom Poultry Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Test Type
7.3.2.2.2. By Disease Type
7.3.3. Italy Poultry Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Test Type
7.3.3.2.2. By Disease Type
7.3.4. France Poultry Diagnostics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Test Type
7.3.4.2.2. By Disease Type
7.3.5. Spain Poultry Diagnostics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Test Type
7.3.5.2.2. By Disease Type
8. Asia-Pacific Poultry Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test Type
8.2.2. By Disease Type
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Poultry Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Test Type
8.3.1.2.2. By Disease Type
8.3.2. India Poultry Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Test Type
8.3.2.2.2. By Disease Type
8.3.3. Japan Poultry Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Test Type
8.3.3.2.2. By Disease Type
8.3.4. South Korea Poultry Diagnostics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Test Type
8.3.4.2.2. By Disease Type
8.3.5. Australia Poultry Diagnostics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Test Type
8.3.5.2.2. By Disease Type
9. South America Poultry Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Test Type
9.2.2. By Disease Type
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Poultry Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Test Type
9.3.1.2.2. By Disease Type
9.3.2. Argentina Poultry Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Test Type
9.3.2.2.2. By Disease Type
9.3.3. Colombia Poultry Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Test Type
9.3.3.2.2. By Disease Type
10. Middle East and Africa Poultry Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Test Type
10.2.2. By Disease Type
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Poultry Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Test Type
10.3.1.2.2. By Disease Type
10.3.2. Saudi Arabia Poultry Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Test Type
10.3.2.2.2. By Disease Type
10.3.3. UAE Poultry Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Test Type
10.3.3.2.2. By Disease Type
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Zoetis Services LLC
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. QIAGEN N.V.
14.3. BioChek BV
14.4. Bioneer Corporation
14.5. Thermo Fisher Scientific Inc.
14.6. MEGACOR Diagnostik GmbH
14.7. IDEXX Laboratories, Inc.
14.8. Randox Laboratories Ltd.
14.9. INDICAL Bioscience GmbH
14.10. Heska Corporation
15. Strategic Recommendations
16. About Us & Disclaimer